| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |